Bruker (BRKR) Is Today's Strong And Under The Radar Stock

Trade-Ideas LLC identified Bruker (BRKR) as a strong and under the radar candidate
By TheStreet Wire ,

Trade-Ideas LLC identified

Bruker

(

BRKR

) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified Bruker as such a stock due to the following factors:

  • BRKR has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $28.4 million.
  • BRKR has traded 98.5969999999999942019712761975824832916259765625 options contracts today.
  • BRKR is making at least a new 3-day high.
  • BRKR has a PE ratio of 52.
  • BRKR is mentioned 1.16 times per day on StockTwits.
  • BRKR has not yet been mentioned on StockTwits today.
  • BRKR is currently in the upper 20% of its 1-year range.
  • BRKR is in the upper 35% of its 20-day range.
  • BRKR is in the upper 45% of its 5-day range.
  • BRKR is currently trading above yesterday's high.

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in BRKR with the Ticky from Trade-Ideas. See the FREE profile for BRKR NOW at Trade-Ideas

More details on BRKR:

Bruker Corporation, together with its subsidiaries, designs, manufactures, sells, and services proprietary life science and materials research systems, and associated products worldwide. It operates through two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. BRKR has a PE ratio of 52. Currently there are 4 analysts that rate Bruker a buy, no analysts rate it a sell, and 9 rate it a hold.

The average volume for Bruker has been 678,100 shares per day over the past 30 days. Bruker has a market cap of $3.5 billion and is part of the health care sector and health services industry. The stock has a beta of 0.99 and a short float of 5% with 3.24 days to cover. Shares are up 8.3% year-to-date as of the close of trading on Monday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Bruker as a

hold

. The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we find that revenues have generally been declining.

Highlights from the ratings report include:

  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Life Sciences Tools & Services industry. The net income increased by 114.5% when compared to the same quarter one year prior, rising from $5.50 million to $11.80 million.
  • The current debt-to-equity ratio, 0.48, is low and is below the industry average, implying that there has been successful management of debt levels. Along with the favorable debt-to-equity ratio, the company maintains an adequate quick ratio of 1.15, which illustrates the ability to avoid short-term cash problems.
  • Looking at where the stock is today compared to one year ago, we find that it is not only higher, but it has also clearly outperformed the rise in the S&P 500 over the same period. Although other factors naturally played a role, the company's strong earnings growth was key. Looking ahead, the stock's rise over the last year has already helped drive it to a level which is relatively expensive compared to the rest of its industry, implying reduced upside potential.
  • BRKR, with its decline in revenue, slightly underperformed the industry average of 5.4%. Since the same quarter one year prior, revenues slightly dropped by 5.6%. The declining revenue has not hurt the company's bottom line, with increasing earnings per share.
  • The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. In comparison to the other companies in the Life Sciences Tools & Services industry and the overall market, BRUKER CORP's return on equity is significantly below that of the industry average and is below that of the S&P 500.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Loading ...